Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Vesely

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2022
Cancer Immunoediting in the Era of Immuno-oncologyMatthew M Gubin, Matthew D Vesely
The Journal of Clinical Investigation|January 2, 2025
Type 2 immunity to the rescue: enhancing antitumor immunity for skin cancer preventionMatthew D Vesely, Sean R Christensen
The Yale Journal of Biology and Medicine|April 1, 2020
Cutaneous Lupus Erythematosus: Current and Future Pathogenesis-Directed TherapiesAlicia J Little, Matthew D Vesely
JAAD Case Reports|December 15, 2020
Onychodystrophy associated with dupilumab therapy for atopic dermatitisAmanda E Zubek, Matthew D Vesely
Annual Review of Immunology|April 26, 2022
Resistance Mechanisms to Anti-PD Cancer ImmunotherapyMatthew D Vesely, Tianxiang Zhang, Lieping Chen
JAAD Case Reports|January 5, 2017
Tofacitinib citrate for the treatment of refractory, severe chronic actinic dermatitisMatthew D Vesely, Suguru Imaeda, Brett A King
Lancet (London, England)|November 14, 2021
A pruritic psoriatic plaque develops at the donor site of an autologous skin graft: Koebner phenomenonMichael J Murphy, William Damsky, Matthew D Vesely
Cutis|July 5, 2023
Crusted Scabies Presenting as Erythroderma in a Patient With Iatrogenic Immunosuppression for Treatment of Granulomatosis With PolyangiitisBrianna Olamiju, Jonathan S Leventhal, Matthew D Vesely
JAAD Case Reports|April 21, 2022
Treatment of lichen sclerosus and hypertrophic scars with dupilumabDanielle M Peterson, William E Damsky, Matthew D Vesely
JAMA|March 21, 2022
Fever, Hypotension, and a Worsening Necrotic WoundDanielle M Peterson, William E Damsky, Matthew D Vesely
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2022
Cancer Immunoediting in the Era of Immuno-oncologyMatthew M Gubin, Matthew D Vesely
The Journal of Clinical Investigation|January 2, 2025
Type 2 immunity to the rescue: enhancing antitumor immunity for skin cancer preventionMatthew D Vesely, Sean R Christensen
The Yale Journal of Biology and Medicine|April 1, 2020
Cutaneous Lupus Erythematosus: Current and Future Pathogenesis-Directed TherapiesAlicia J Little, Matthew D Vesely
JAAD Case Reports|December 15, 2020
Onychodystrophy associated with dupilumab therapy for atopic dermatitisAmanda E Zubek, Matthew D Vesely
Annual Review of Immunology|April 26, 2022
Resistance Mechanisms to Anti-PD Cancer ImmunotherapyMatthew D Vesely, Tianxiang Zhang, Lieping Chen
JAAD Case Reports|January 5, 2017
Tofacitinib citrate for the treatment of refractory, severe chronic actinic dermatitisMatthew D Vesely, Suguru Imaeda, Brett A King
Lancet (London, England)|November 14, 2021
A pruritic psoriatic plaque develops at the donor site of an autologous skin graft: Koebner phenomenonMichael J Murphy, William Damsky, Matthew D Vesely
Cutis|July 5, 2023
Crusted Scabies Presenting as Erythroderma in a Patient With Iatrogenic Immunosuppression for Treatment of Granulomatosis With PolyangiitisBrianna Olamiju, Jonathan S Leventhal, Matthew D Vesely
JAAD Case Reports|April 21, 2022
Treatment of lichen sclerosus and hypertrophic scars with dupilumabDanielle M Peterson, William E Damsky, Matthew D Vesely
JAMA|March 21, 2022
Fever, Hypotension, and a Worsening Necrotic WoundDanielle M Peterson, William E Damsky, Matthew D Vesely
Pageof 6